Studie
GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies
PRIMÄR
Tier 3
2025
StudiedesignPRIMÄR
TierNivå 3, Blandad humana bevis, mekanism trovärdig
År2025
TidskriftDiabetes Metab
N5
Tillagd i NO1GEVITYmaj 12, 2026
Citerad av
1 encyklopediartiklar refererar till denna studie.